OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.67 Million Position in GP-Act III Acquisition Corp. $GPAT

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its position in GP-Act III Acquisition Corp. (NASDAQ:GPAT) by 28.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 250,000 shares of the company’s stock after selling 100,000 shares during the quarter. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in GP-Act III Acquisition were worth $2,675,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also added to or reduced their stakes in the company. Longfellow Investment Management Co. LLC acquired a new stake in GP-Act III Acquisition in the third quarter valued at $83,000. Bank of America Corp DE bought a new position in shares of GP-Act III Acquisition during the third quarter worth about $85,000. Clear Street Group Inc. acquired a new position in shares of GP-Act III Acquisition in the third quarter worth approximately $109,000. Cannon Global Investment Management LLC lifted its stake in shares of GP-Act III Acquisition by 38.1% in the fourth quarter. Cannon Global Investment Management LLC now owns 14,500 shares of the company’s stock worth $155,000 after acquiring an additional 4,000 shares during the period. Finally, Schonfeld Strategic Advisors LLC bought a new stake in GP-Act III Acquisition in the third quarter valued at approximately $203,000.

GP-Act III Acquisition Stock Performance

Shares of NASDAQ GPAT opened at $10.88 on Friday. The stock’s 50 day moving average price is $10.88 and its two-hundred day moving average price is $10.79. GP-Act III Acquisition Corp. has a 52-week low of $10.50 and a 52-week high of $12.00.

GP-Act III Acquisition (NASDAQ:GPAT) last issued its quarterly earnings results on Thursday, May 14th. The company reported $0.06 earnings per share for the quarter.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of GP-Act III Acquisition in a research report on Tuesday, April 21st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has an average rating of “Sell”.

GP-Act III Acquisition Profile

GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.